- Home
- ORIC vs ECPG Comparison
ORIC vs ECPG Comparison
Compare ORIC & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- ECPG
- Stock Information
- Founded
- ORIC 2014
- ECPG 1998
- Country
- ORIC United States
- ECPG United States
- Employees
- ORIC N/A
- ECPG N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- ECPG Finance Companies
- Sector
- ORIC Health Care
- ECPG Finance
- Exchange
- ORIC Nasdaq
- ECPG Nasdaq
- Market Cap
- ORIC 1.1B
- ECPG 905.2M
- IPO Year
- ORIC 2020
- ECPG 1999
- Fundamental
- Price
- ORIC $12.20
- ECPG $49.63
- Analyst Decision
- ORIC Strong Buy
- ECPG Strong Buy
- Analyst Count
- ORIC 8
- ECPG 3
- Target Price
- ORIC $17.86
- ECPG $61.67
- AVG Volume (30 Days)
- ORIC 1.1M
- ECPG 237.3K
- Earning Date
- ORIC 11-13-2025
- ECPG 11-05-2025
- Dividend Yield
- ORIC N/A
- ECPG N/A
- EPS Growth
- ORIC N/A
- ECPG N/A
- EPS
- ORIC N/A
- ECPG N/A
- Revenue
- ORIC N/A
- ECPG $1,560,869,000.00
- Revenue This Year
- ORIC N/A
- ECPG $27.55
- Revenue Next Year
- ORIC N/A
- ECPG $5.84
- P/E Ratio
- ORIC N/A
- ECPG N/A
- Revenue Growth
- ORIC N/A
- ECPG 17.52
- 52 Week Low
- ORIC $3.90
- ECPG $26.45
- 52 Week High
- ORIC $14.93
- ECPG $51.77
- Technical
- Relative Strength Index (RSI)
- ORIC 46.07
- ECPG 64.39
- Support Level
- ORIC $12.02
- ECPG $41.10
- Resistance Level
- ORIC $13.04
- ECPG $50.18
- Average True Range (ATR)
- ORIC 0.75
- ECPG 1.79
- MACD
- ORIC -0.12
- ECPG 0.64
- Stochastic Oscillator
- ORIC 20.69
- ECPG 82.74
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.